NCT04787770View on ClinicalTrials.gov

The Role of HSP90 in Peripheral Vascular Lesions of Diabetic Atherosclerosis

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

November 10, 2020

Study Completion Date

December 10, 2020

Conditions
Peripheral Arterial Disease
Interventions
OTHER

non-intervention

non-intervention

Trial Locations (1)

510515

Nanfang Hospital, Guangzhou

All Listed Sponsors
lead

Nanfang Hospital, Southern Medical University

OTHER

NCT04787770 - The Role of HSP90 in Peripheral Vascular Lesions of Diabetic Atherosclerosis | Biotech Hunter | Biotech Hunter